Aceragen | IDRA - Кредиторская задолженность



Кредиторская задолженность Изменить Дата
Abbott USD 4.12B 183M 2025-09
Agenus USD 82.99M 2.3M 2025-12
Alnylam Pharmaceuticals USD 115.72M 1.87M 2025-12
Alterity Therapeutics Limited AUD 1.27M 1.81M 2024-12
Amgen USD 20.89B 1.25B 2025-12
Biogen USD 432M 18.9M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Cipla INR 30.35B 1.98B 2025-09
Clal Biotechnology ILS 21.05M 1.62M 2021-12
Compugen USD 2.35M 6.77M 2025-12
CSL USD 3.17B 290M 2025-12
Eli Lilly USD 5.38B 1.12B 2025-12
Gilead Sciences USD 808M 226M 2025-09
GlaxoSmithKline GBP 15.38B 294M 2025-12
Grifols EUR 987.75M 47.87M 2025-12
Merck USD 4.15B 102M 2025-09
Nektar Therapeutics USD 15.56M 1.28M 2025-09
Pfizer USD 5.02B 142M 2025-09
Roche Holding CHF 5.78B 1.27B 2025-12
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
X T L Biopharmaceuticals USD 638K 442K 2025-06